CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

BRCA1/2 pathogenic variant

Gene: BRCA1/BRCA2 · Type: mutation

Indications: Breast cancer, Ovarian cancer, Prostate cancer, Pancreatic cancer

SensitivityResistanceCIViC Context

FDA Resistance Assertions

No resistance assertions.